Disease areas:
  • nutrition and metabolism
Last updated:
Author(s):
Danni A. Gadd, Robert F. Hillary, Zhana Kuncheva, Tasos Mangelis, Yipeng Cheng, Manju Dissanayake, Romi Admanit, Jake Gagnon, Tinchi Lin, Kyle L. Ferber, Heiko Runz, Christopher N. Foley, Riccardo E. Marioni, Benjamin B. Sun
Publish date:
10 July 2024
Journal:
Nature Aging
PubMed ID:
38987645

Abstract

The circulating proteome offers insights into the biological pathways that underlie disease. Here, we test relationships between 1,468 Olink protein levels and the incidence of 23 age-related diseases and mortality in the UK Biobank (n = 47,600). We report 3,209 associations between 963 protein levels and 21 incident outcomes. Next, protein-based scores (ProteinScores) are developed using penalized Cox regression. When applied to test sets, six ProteinScores improve the area under the curve estimates for the 10-year onset of incident outcomes beyond age, sex and a comprehensive set of 24 lifestyle factors, clinically relevant biomarkers and physical measures. Furthermore, the ProteinScore for type 2 diabetes outperforms a polygenic risk score and HbA1c – a clinical marker used to monitor and diagnose type 2 diabetes. The performance of scores using metabolomic and proteomic features is also compared. These data characterize early proteomic contributions to major age-related diseases, demonstrating the value of the plasma proteome for risk stratification.

Related projects

Overall success rates for bringing novel medicines to patients are low. Reasons for failure in drug discovery and clinical development are many and complex, including…

Institution:
GlaxoSmithKline, USA, United States of America

1. The primary scientific goal of the research is to apply human genetics to the identification of new drug targets, the validation of existing targets…

Institution:
Regeneron Genetics Center, LLC, United States of America

This project aims to study how a person’s genes affects the risk and progression of a broad range of diseases and medical conditions including cancer,…

Institution:
Genentech, Inc., United States of America

The aim of the proposed research is to understand comorbidities in cardiometabolic diseases. In particular, to answer the following questions: what are the biological mechanisms…

Institution:
Novo Nordisk Research Centre Oxford Ltd, Great Britain

Whole genome sequencing of samples from the UK Biobank will lead to the identification of genetic variants within the human genome that can be associated…

Institution:
Amgen Inc, United States of America

All projects